… development and reaching important revenue-bearing milestones. This … QUVIVIQ® began in the fourth quarter of the prior year, … . This change in profitability reflects the combined effect … –END– About Nxera Pharma Nxera Pharma is a technology powered biopharma …

… 1.23%), a pharmaceutical company focused on therapies … revenue. This period marked a return to profitability … could cause revenue variability quarter to quarter. Royalty revenue, reflecting sub … trials expected in Q4 2025. Research and development …

… fourth quarter of fiscal 2025, including one with a large, multinational pharmaceutical … fourth quarter and fiscal year resulted in improved operational efficiency and profitability … Consolidated Fourth Quarter Fiscal 2025 Financial Results Revenues for the …

… expected in the fourth quarter of 2025. … Consolidated Statement of Profit or (Loss)               Revenue 158,045   … to profit or (loss):               Exchange differences … )   (240,337 )                   Ascendis Pharma A/S Consolidated Statements …

… its stock exchange filing. While profits took a hit, the company … .1 per cent increase in revenue from operations, reaching Rs 794 … used in the chemical and pharmaceutical industries, has been expanding globally … at Rs 43 crore for Q4 FY25 and Rs 50.4 …

… $150 billion in industry-wide revenue by the early 2030s, thanks … are weekly injections, although several drugmakers are racing to develop an … in the fourth quarter. MERCK The company, in partnership with Hansoh Pharma, is …

… Transcript August 6, 2025 Lexicon Pharmaceuticals, Inc. beats earnings expectations … Welcome to the Lexicon Pharmaceuticals Second Quarter 2025 Financial Results … work is completed. Total revenues for the quarter also … sota as early as Q4 of this year, which …

… the FDA in the fourth quarter,” said Tom McCourt … of collaborative arrangements revenue. 3 Includes certain … total net profit (loss) generated from the … OTHER HEALTH HEALTH PHARMACEUTICAL CLINICAL TRIALS SOURCE: Ironwood Pharmaceuticals, Inc. Copyright …

… Financial Results: Revenue: Net revenues for the second … products late in the fourth quarter of 2023. Research … About Phathom Pharmaceuticals, Inc. Phathom Pharmaceuticals is a … revenues; our goals and beliefs with respect to potential profitability …

… Mumbai-based company's revenue from operations dropped by 6 … reported in the previous quarter (Q4 FY25). Total income for the … the quarter, compared to a profit of Rs 6.9 crore … in providing solutions across the pharmaceutical, animal health, biotech, crop …